ストックスクリーナーアプリを入手
0.7449
2.27%
0.0165
アフターアワーズ：
.75
0.0051
+0.68%
前日終値:
$0.7284
開ける：
$0.75
24時間の取引高:
2.67M
Relative Volume:
0.54
時価総額：
$161.28M
収益：
-
当期純損益:
$-111.13M
株価収益率:
-0.5643
EPS:
-1.32
ネットキャッシュフロー:
$-91.53M
1週間 パフォーマンス:
+6.41%
1か月 パフォーマンス:
-47.17%
6か月 パフォーマンス:
+21.74%
1年 パフォーマンス:
-50.99%
1日の値動き範囲:
$0.7181
$0.7625
1週間の範囲:
$0.68
$0.7627
52週間の値動き範囲:
$0.36
$2.35
Tenaya Therapeutics Inc Stock (TNYA) Company Profile
名前
Tenaya Therapeutics Inc
セクター
電話
415-865-2066
住所
171 OYSTER POINT BLVD., SUITE 500, SOUTH SAN FRANCISCO
TNYA を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
TNYA
Tenaya Therapeutics Inc
|
0.7449 | 157.70M | 0 | -111.13M | -91.53M | -1.32 |
|
VRTX
Vertex Pharmaceuticals Inc
|
468.38 | 113.87B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
776.54 | 80.22B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
406.40 | 52.56B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
803.74 | 49.31B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.07 | 37.37B | 447.02M | -1.18B | -906.14M | -6.1812 |
Tenaya Therapeutics Inc Stock (TNYA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-06-10 | 開始されました | William Blair | Outperform |
| 2023-11-30 | 開始されました | Leerink Partners | Outperform |
| 2022-06-15 | 開始されました | H.C. Wainwright | Buy |
Tenaya Therapeutics Inc (TNYA) 最新ニュース
Tenaya Therapeutics Inc. (TNYA) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Tenaya Therapeutics announces orderly board leadership transition - TipRanks
Buy Signal: Is Tenaya Therapeutics Inc stock supported by strong fundamentalsPortfolio Update Report & Daily Volume Surge Signals - moha.gov.vn
How Tenaya Therapeutics Inc. stock reacts to Fed rate cutsLow Beta Stocks & Budget Friendly Investment Plans - bollywoodhelpline.com
Tenaya Therapeutics, Inc. (NASDAQ:TNYA) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Gene therapy genie back in the bottle? - BioWorld MedTech
Tenaya Therapeutics price target lowered to $4 from $6 at Canaccord - MSN
Why Tenaya Therapeutics Inc. stock is rated strong buy2025 Price Momentum & Free Expert Verified Stock Movement Alerts - Bölüm Sonu Canavarı
Buyout Rumor: Why Tenaya Therapeutics Inc stock is recommended by analystsMarket Activity Report & Reliable Trade Execution Plans - moha.gov.vn
Is International Seaways Inc stock attractive for ETFsMarket Risk Analysis & Smart Money Movement Tracker - moha.gov.vn
Leerink Partners Reaffirms Their Buy Rating on Tenaya Therapeutics (TNYA) - The Globe and Mail
Will Tenaya Therapeutics Inc. stock outperform growth indexesWeekly Market Outlook & Long Hold Capital Preservation Plans - Улправда
Is Tenaya Therapeutics Inc. stock positioned for long term growth2025 Performance Recap & Low Drawdown Momentum Ideas - Улправда
Will Tenaya Therapeutics Inc. stock remain a Wall Street favorite2025 Top Gainers & Consistent Profit Trading Strategies - DonanımHaber
Will Tenaya Therapeutics Inc. stock deliver shareholder valueQuarterly Investment Review & Expert-Curated Trade Recommendations - DonanımHaber
Canaccord Genuity Keeps Their Buy Rating on Tenaya Therapeutics (TNYA) - The Globe and Mail
Sell Signal: What catalysts could drive Tenaya Therapeutics Inc. stock higher2025 Key Lessons & Proven Capital Preservation Tips - Улправда
Tenaya Therapeutics stock price target lowered to $5 at Canaccord By Investing.com - Investing.com Canada
FY2025 Earnings Forecast for TNYA Issued By Lifesci Capital - MarketBeat
Tenaya Therapeutics stock price target lowered to $5 at Canaccord - Investing.com India
Wilson Sonsini Advises Tenaya Therapeutics on Pricing of Public Offering - Wilson Sonsini
H.C. Wainwright lowers Tenaya Therapeutics stock price target to $3 on ARVC trial data By Investing.com - Investing.com Australia
Tenaya fundraising follows resolution of clinical hold - The Pharma Letter
H.C. Wainwright lowers Tenaya Therapeutics stock price target to $3 on ARVC trial data - Investing.com Nigeria
Tenaya Therapeutics announces proposed public offering - MSN
Tenaya Therapeutics price target lowered to $3 from $5 at HC Wainwright - MSN
Tenaya Therapeutics (TNYA) Is Down 39.7% After Cardiac Gene Therapy Milestones And $60M FundraiseWhat's Changed - Yahoo Finance
Tenaya Therapeutics announces clinical hold on MyPEAK-1 trial lifted by FDA - MSN
Tenaya Therapeutics (NASDAQ:TNYA) Given New $3.00 Price Target at HC Wainwright - MarketBeat
Chardan Capital Lowers Tenaya Therapeutics (NASDAQ:TNYA) Price Target to $8.00 - MarketBeat
Tenaya Therapeutics Announces Public Offering Pricing - The Globe and Mail
Chardan Capital Maintains Tenaya Therapeutics (TNYA) Buy Recommendation - Nasdaq
HC Wainwright & Co. Maintains Tenaya Therapeutics (TNYA) Buy Recommendation - Nasdaq
Tenaya Therapeutics (NASDAQ: TNYA) details $60 million unit and warrant sale - Stock Titan
Pharma News: Will Tenaya Therapeutics Inc stock remain a Wall Street favorite2025 Market Sentiment & Weekly Return Optimization Plans - moha.gov.vn
Tenaya Stock Plunges After $60 Million Equity Offering - Sahm
Tenaya Stock Drops After Announcing $60M Equity OfferingTenaya Therapeutics (NASDAQ:TNYA) - Benzinga
Tenaya Therapeutics (TNYA) Price Target Lowered by HC Wainwright & Co. | TNYA Stock News - GuruFocus
Tenaya Therapeutics slumps after $60 million share sale - TradingView — Track All Markets
Tenaya Therapeutics plans to offer stock and warrant units By Investing.com - Investing.com India
Tenaya Therapeutics Prices 50 Mln Unit Offering At $60 Mln, Clinical Hold Lifted On TN-201 - Nasdaq
Tenaya Therapeutics announces positive data from Phase 1b/2 trial - Traders Union
TNYA: Chardan Capital Lowers Price Target While Maintaining Buy Rating | TNYA Stock News - GuruFocus
FDA lifts clinical hold on Tenaya’s heart disease gene therapy trial - Investing.com Australia
Tenaya Therapeutics Prices $60 Million Unit Offering - marketscreener.com
Tenaya Therapeutics prices $60 million public offering of stock and warrants - Investing.com Nigeria
Tenaya Therapeutics Announces Pricing of Public Offering - The Manila Times
Tenaya Therapeutics prices $60 million public offering of stock and warrants By Investing.com - Investing.com South Africa
Tenaya Therapeutics Announces Pricing of Public Offering | Associated Press | syndication news - Enidnews.com
Tenaya Therapeutics presents new interim safety, efficacy data on TN-201 - MSN
Tenaya Therapeutics stock falls on proposed share and warrant offering By Investing.com - Investing.com Canada
Tenaya Therapeutics Inc (TNYA) 財務データ
収益
当期純利益
現金流量
EPS
2.52%
0.07%
大文字化:
|
ボリューム (24 時間):